Breaking News Instant updates and real-time market news.

TCEHY

Tencent

$0.00

(0.00%)

12:11
08/29/18
08/29
12:11
08/29/18
12:11

Tencent's Riot Games outlines steps to improve workplace culture

In response to allegations and reports of toxic workplace conditions, Tencent's Riot Games issued a statement saying that it has been "focused on listening and learning" for the past three weeks. "As a company, we're used to patching problems ASAP, but this patch will not happen overnight," Riot said. "We will weave this change into our cultural DNA and leave no room for sexism or misogyny. Inclusivity, diversity, respect, and equality are all non-negotiable. While there is much to improve, there is a tremendous amount of good at Riot that will drive this change. This is our top priority until we get it right." The company apologized to its current and former employees, players, prospective employees, and partners, adding that it is "committed to do things the right way," knowing that "the change we need isn't going to happen overnight." Riot, which is famous for making popular esports title "League of Legends," said it is taking a number of steps to correct its workplace conditions, through expanding the culture and diversity and inclusion initiative, revisiting cultural definitions, engaging consultants for a third-party evaluation, improving its investigation process, reevaluating recruiting, doubling down on trainings, and staffing up for diversity and inclusion. Reference Link

TCEHY Tencent
$0.00

(0.00%)

08/15/18
BNCH
08/15/18
NO CHANGE
Target $12
BNCH
Buy
Vipshop price target lowered to $12 from $19 at Benchmark
Benchmark analyst Fawne Jiang lowered her price target on Vipshop (VIPS) to $12 after the company reported soft Q2 results and gave Q3 guidance that indicated an organic revenue deceleration on top of a limited contribution from the Tencent (TCEHY) and JD.com (JD) channels. She believes Vipshop continues to face growth challenges due to increasing competition and changing industry dynamics in China, but keeps a Buy rating on the shares as she expects significant synergies to be unlocked from the Tencent and JD partnerships over the longer-term.
08/16/18
JEFF
08/16/18
NO CHANGE
Target $90
JEFF
Buy
China approval freeze creates buying opportunity in Activision, says Jefferies
Jefferies analyst Timothy O'Shea said he views China having frozen mobile game approvals as a temporary problem and "mostly a non-issue" as only the monetization approval process has been frozen, not the content approval process, and he note administrators are already implementing a fast-track approval process to alleviate the problem. Activision Blizzard's (ATVI) upcoming Call of Duty mobile game was expected to launch in China this year, but O'Shea said this is a smaller game that is not in his estimates, adding that Tencent (TCEHY) gets 70% of the revenue under its deal for the game. Activision has a pipeline of new mobile games coming that he would still expect to launch in China over time and O'Shea sees the 15% pullback in the game maker's shares in the last month as a buying opportunity, he tells investors. He maintains a Buy rating and $90 price target on Activision Blizzard shares.
08/20/18
NOMU
08/20/18
NO CHANGE
NOMU
Buy
China watchdogs said to likely restart game reviews soon, says Nomura Instinet
Nomura Instinet analyst Jialong Shi noted that over the weekend posts on Weibo said China's online game watchdogs will likely restart game reviews as early as September, adding that a few of his online gaming contacts have also heard lately from relevant watchdogs that the review of new games should restart soon. If game reviews do resume in September, Tencent's (TCEHY) PUBG Mobile and Fortnite are likely to receive licenses for monetization in Q4 at the earliest, said Shi, who believes Tencent and NetEase (NTES) would benefit from improved sentiment and outlooks if Chinese regulators restart reviews.
08/22/18
LEHM
08/22/18
NO CHANGE
Target $55
LEHM
Overweight
Tencent price target lowered to $55 from $59 at Barclays
Barclays analyst Gregory Zhao lowered his price target for Tencent Holdings to $55 following the company's Q2 results to reflect the impact from monetization approval delay to mobile gaming revenue as well as the negative efforts to interest revenue due to the deposit rate increase. The analyst keeps an Overweight rating on the shares.

TODAY'S FREE FLY STORIES

INDB

Independent Bank

$89.85

0.65 (0.73%)

, BHBK

Blue Hills Bancorp

$23.55

0.4 (1.73%)

16:16
09/20/18
09/20
16:16
09/20/18
16:16
Hot Stocks
Independent Bank, Blue Hills sign merger pact for Rockland to acquire BHB »

Independent Bank Corp.…

INDB

Independent Bank

$89.85

0.65 (0.73%)

BHBK

Blue Hills Bancorp

$23.55

0.4 (1.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PIR

Pier 1 Imports

$1.80

0.045 (2.56%)

16:16
09/20/18
09/20
16:16
09/20/18
16:16
Earnings
Pier 1 Imports reports preliminary Q2 EPS (64c)-(62c), consensus (55c) »

Reports Q2 prelim SSS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOD

Gladstone

$19.01

0.28 (1.49%)

16:16
09/20/18
09/20
16:16
09/20/18
16:16
Hot Stocks
Gladstone acquires $8.3M property in Delaware, Ohio »

Gladstone Commercial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
09/20/18
09/20
16:16
09/20/18
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$46.03

0.98 (2.18%)

16:15
09/20/18
09/20
16:15
09/20/18
16:15
Hot Stocks
Micron appoints Mike Bokan SVP Worldwide Sales »

Micron Technology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 20

    Sep

  • 24

    Sep

  • 25

    Sep

16:15
09/20/18
09/20
16:15
09/20/18
16:15
General news
Breaking General news story  »

Week of 9/10 Money Supply…

16:15
09/20/18
09/20
16:15
09/20/18
16:15
General news
Breaking General news story  »

Week of 9/19 Fed Balance…

ADVM

Adverum Biotechnologies

$5.70

-0.15 (-2.56%)

16:14
09/20/18
09/20
16:14
09/20/18
16:14
Initiation
Adverum Biotechnologies initiated  »

Adverum Biotechnologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

GBL

GAMCO Investors

$26.00

0.44 (1.72%)

, GCP

GCP Applied Technologies

$26.25

0.25 (0.96%)

16:14
09/20/18
09/20
16:14
09/20/18
16:14
Hot Stocks
Breaking Hot Stocks news story on GAMCO Investors, GCP Applied Technologies »

Gabelli reports 5% stake…

GBL

GAMCO Investors

$26.00

0.44 (1.72%)

GCP

GCP Applied Technologies

$26.25

0.25 (0.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSLT

Castlight Health

$2.90

0.1 (3.57%)

16:13
09/20/18
09/20
16:13
09/20/18
16:13
Hot Stocks
Breaking Hot Stocks news story on Castlight Health »

Neil Gagnon reports 5.5%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNFI

United Natural Foods

$33.87

0.575 (1.73%)

16:12
09/20/18
09/20
16:12
09/20/18
16:12
Hot Stocks
Breaking Hot Stocks news story on United Natural Foods »

United Natural Foods down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 28

    Oct

UNFI

United Natural Foods

$33.79

0.5 (1.50%)

16:12
09/20/18
09/20
16:12
09/20/18
16:12
Hot Stocks
United Natural Foods says results reflect higher than anticipated freight costs »

"We continued to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 28

    Oct

SCS

Steelcase

$16.10

0.8 (5.23%)

16:11
09/20/18
09/20
16:11
09/20/18
16:11
Hot Stocks
Breaking Hot Stocks news story on Steelcase »

Steelcase up 9.9% after…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

FATE

Fate Therapeutics

$13.99

0.64 (4.79%)

16:11
09/20/18
09/20
16:11
09/20/18
16:11
Syndicate
Fate Therapeutics files to sell common stock, no amount given »

Jefferies, Piper Jaffray,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

SCS

Steelcase

$16.10

0.8 (5.23%)

16:10
09/20/18
09/20
16:10
09/20/18
16:10
Earnings
Breaking Earnings news story on Steelcase »

Steelcase sees FY19 EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

T

AT&T

$33.38

0.02 (0.06%)

16:10
09/20/18
09/20
16:10
09/20/18
16:10
Hot Stocks
AT&T recommends that shareholders reject mini-tender from Ponos Industries »

AT&T has learned that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 21

    Oct

  • 06

    Nov

  • 12

    Nov

BHBK

Blue Hills Bancorp

$23.50

0.35 (1.51%)

16:10
09/20/18
09/20
16:10
09/20/18
16:10
Hot Stocks
Breaking Hot Stocks news story on Blue Hills Bancorp »

Blue Hills Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KPTI

Karyopharm

$18.98

0.49 (2.65%)

16:09
09/20/18
09/20
16:09
09/20/18
16:09
Hot Stocks
Karyopharm announces oral presentation relating to selinexor »

Karyopharm Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

SCS

Steelcase

$16.05

0.75 (4.90%)

16:09
09/20/18
09/20
16:09
09/20/18
16:09
Earnings
Steelcase sees Q3 EPS 28c-33c, consensus 25c »

Sees Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

UNFI

United Natural Foods

$33.89

0.6 (1.80%)

16:09
09/20/18
09/20
16:09
09/20/18
16:09
Hot Stocks
United Natural Foods reports Q4 gross margin 14.5% down 125 bps y/y »

Gross margin for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 28

    Oct

OPNT

Opiant Pharmaceuticals

$22.41

0.36 (1.63%)

16:09
09/20/18
09/20
16:09
09/20/18
16:09
Hot Stocks
Opiant Pharmaceuticals enters into $4.6M contract with BARDA for OPTN003 »

Opiant Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

UNFI

United Natural Foods

$33.92

0.63 (1.89%)

16:08
09/20/18
09/20
16:08
09/20/18
16:08
Hot Stocks
United Natural Foods sees FY19 effective tax rate 27.4%-28.4% »

Sees FY19 free cash flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 28

    Oct

SCS

Steelcase

$16.05

0.75 (4.90%)

16:07
09/20/18
09/20
16:07
09/20/18
16:07
Earnings
Steelcase reports Q2 EPS 41c, consensus 29c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

EDR

EdR

$41.49

(0.00%)

16:07
09/20/18
09/20
16:07
09/20/18
16:07
Hot Stocks
EdR acquired by Greystar Real Estate for $4.6B »

EdR's acquisition…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNFI

United Natural Foods

$33.87

0.58 (1.74%)

16:07
09/20/18
09/20
16:07
09/20/18
16:07
Earnings
United Natural Foods sees FY19 adjusted EPS $3.48-$3.58, consensus $3.54 »

Sees FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 28

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.